Obtusilactone B from Machilus Thunbergii targets barrier-to-autointegration factor to treat cancer
Targeting specific molecules is a promising cancer treatment because certain types of cancer cells are dependent on specific oncogenes. This strategy led to the development of therapeutics that use monoclonal antibodies or small-molecule inhibitors. However, the continued development of novel molecu...
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Autres auteurs: | |
| Format: | Journal Article |
| Langue: | English |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://hdl.handle.net/10356/102247 http://hdl.handle.net/10220/19055 |